Computed tomography angiography in patients with suspected pulmonary embolism-too often considered?

BACKGROUND: Pulmonary embolism (PE) is a major cause of morbidity and mortality associated with surgery and medical illnesses. In recent years, pulmonary computed tomography angiography (CTA) has become the diagnostic method of choice. However, it remains unclear when to perform CTA and how often a decision based on clinical judgment results in positive or negative findings. METHODS: In a retrospective study, 261 patients admitted for suspected PE were evaluated with pulmonary CTA. Decisions to order CTA were based on clinical judgment and optionally quantitative d-dimer assays. Clinical, radiologic, and laboratory data were revisited and compared in patients with and without proven PE. RESULTS: The patients' mean age was 63 ± 1 years; almost 30% of all participants had at least a moderately reduced renal function. Pulmonary CTA demonstrated PE in only 14.9%; both age and sex distribution was comparable in the PE and non-PE group. Proximal deep vein thrombosis or pathologic chest x-rays were significantly more likely in patients with PE (P < .001 and P < .05), whereas echocardiography results were comparable. d-dimer values were noticeably higher in the PE group (P < .001); however, C-reactive protein and troponin T levels were not helpful. CONCLUSIONS: Pulmonary CTA confirmed PE in only a minority of patients and may be overused. Clinical judgment in conjunction with d-dimer evaluation was of limited help to predict positive results but surprisingly comparable with previous results using pretest probability scoring systems. Using present and previous data, a simplified enhanced algorithm is proposed to reduce use of CTA.

T2* relaxometry in liver, pancreas, and spleen in a healthy cohort of one hundred twenty-nine subjects-correlation with age, gender, and serum ferritin.

OBJECTIVE: To assess T2* values of liver, pancreas, and spleen in a healthy cohort and to compare the gained values with serum ferritin levels and anthropometric data. In addition, the relationship of T2* between the 3 organs was investigated. MATERIALS AND METHODS: One hundred twenty-nine healthy subjects (85 women, 44 men) were examined on a 1.5-T magnetic resonance whole-body unit. Age ranged from 20 to 70 years (mean age, 47.9 +/- 11.4 years). A multislice fat-saturated breath-hold 2D multiecho gradient-echo sequence was applied for T2* measurement. To assess T2* values of the liver, pancreas, and spleen, T2* maps were calculated. The correlation of organ T2* with serum ferritin and anthropometric data (age, gender, body mass index) was investigated. RESULTS: Measurement of T2* was feasible in all volunteers. A gender-related analysis revealed significant higher hepatic and splenic T2* values for women than for men (P < 0.01). For the pancreas, these differences could not be found. A significant negative correlation was found between hepatic T2*, splenic T2*, and serum ferritin (r = -0.62 liver, r = -0.64 spleen; P < 0.0001). In contrast, no such relationship was found for pancreatic T2* (r = -0.15). For women, a statistically significant age-dependent increase was found for splenic T2* values. CONCLUSION: Using a fast quantitative T2* magnetic resonance imaging technique, it was possible to gain insights into the iron metabolism of a healthy cohort. Gender- and age-related differences concerning T2* and serum ferritin levels were found in the liver and spleen, but not in the pancreas.